Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A randomized, double-blind, parallel-group, comparison study of three doses (placebo, MRA 4 mg/kg, or MRA 8 mg/kg) in patients with rheumatoid arthritis
tocilizumab
MRA009JP
NCT00144651
rheumatoid arthritis
Phase 2
 
January 2014

Powered by ideaPoint, Inc.